There is considerable evidence in both mice and humans that prevalence of CD4+CD25+ regulatory T cells (Tregs) is associated with protection from GVHD, and these cells may play an important role in mitigating GVHD pathogenesis through control of effector T cell alloreactivity (146–151). Here, CD4 is linked to graft versus host disease.